Ovarian cancer screening
- PMID: 7884436
- DOI: 10.1200/JCO.1995.13.3.783
Ovarian cancer screening
Abstract
Purpose: To review potential screening tools of early ovarian cancer and the associated risk factors for the development of ovarian carcinoma.
Design and results: A review of pertinent literature was conducted, restricted to English-language published reports, book chapters, and articles. The value of serum tumor markers, particularly CA 125, ultrasound, transabdominal and transvaginal ultrasonography, and transvaginal color Doppler imaging as screening tools for ovarian cancer was assessed.
Conclusion: Based on the literature, a large-scale long-term study that compares the mortality rates of a screened versus unscreened patient population is required before the efficacy of any screening method can be determined definitively.
Similar articles
-
Update on ovarian cancer screening.Curr Opin Obstet Gynecol. 2007 Feb;19(1):22-6. doi: 10.1097/GCO.0b013e328011ec99. Curr Opin Obstet Gynecol. 2007. PMID: 17218847 Review.
-
[Program for early detection of ovarian cancer for women as prophylaxis provided at a municipal hospital].Wiad Lek. 2004;57 Suppl 1:43-7. Wiad Lek. 2004. PMID: 15884203 Polish.
-
Evaluation of transvaginal color Doppler sonography, transvaginal sonography and CA 125 for prediction of ovarian malignancy.Int J Gynaecol Obstet. 1994 Jul;46(1):39-43. doi: 10.1016/0020-7292(94)90307-7. Int J Gynaecol Obstet. 1994. PMID: 7805982 Clinical Trial.
-
Studies on angiogenesis in the benign and malignant ovarian neoplasms with the use of color and pulsed Doppler sonography and serum CA-125, CA-19.9, CA-72.4 and vascular endothelial growth factor measurements.Ann Univ Mariae Curie Sklodowska Med. 2002;57(1):113-31. Ann Univ Mariae Curie Sklodowska Med. 2002. PMID: 12898913
-
Current status of screening for ovarian cancer.Gynecol Oncol. 1994 Dec;55(3 Pt 2):S34-7. doi: 10.1006/gyno.1994.1338. Gynecol Oncol. 1994. PMID: 7835807 Review.
Cited by
-
Characterisation of human kallikrein 6/protease M expression in ovarian cancer.Br J Cancer. 2004 Aug 16;91(4):725-31. doi: 10.1038/sj.bjc.6602041. Br J Cancer. 2004. PMID: 15305183 Free PMC article.
-
Mucins in ovarian cancer diagnosis and therapy.J Ovarian Res. 2009 Dec 24;2:21. doi: 10.1186/1757-2215-2-21. J Ovarian Res. 2009. PMID: 20034397 Free PMC article.
-
Proteomic-based identification of haptoglobin-1 precursor as a novel circulating biomarker of ovarian cancer.Br J Cancer. 2004 Jul 5;91(1):129-40. doi: 10.1038/sj.bjc.6601882. Br J Cancer. 2004. PMID: 15199385 Free PMC article.
-
Forth nightly review: hereditary ovarian carcinoma.BMJ. 1999 Mar 20;318(7186):786-9. doi: 10.1136/bmj.318.7186.786. BMJ. 1999. PMID: 10082707 Free PMC article. Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials